Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Gastrointestinal Hemorrhage 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Deamino Arginine Vasopressin × Clear all
NCT01623206 2017-08-24

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Laboratorio Elea Phoenix S.A.

Phase 2 Completed
30 enrolled
Gastrointestinal

Gastrointestinal Hemorrhage, Colorectal Neoplasms

NCT01606072 2015-08-28

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer

Laboratorio Elea Phoenix S.A.

Phase 2 Completed
21 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡